SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations

Stopped The drug was found to be ineffective against Omicron, so the study was terminated and no patients were enrolled.

Conditions

• SARS-CoV2 Infection
• SARS-CoV-2 Acute Respiratory Disease
• Myeloma
• Leukemia
• Lymphoma
• Immune Thrombocytopenia
• Thrombotic Thrombocytopenic Purpura (TTP)

Interventions

• BIOLOGICAL: BMS-986414
• BIOLOGICAL: BMS-986413

Sponsor

Imperial College Healthcare NHS Trust

Collaborators

• [object Object]
• [object Object]
• [object Object]